Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Poor Survival ◽

Epidermal Growth ◽

Keratin 17 ◽

Estrogen Receptor Negative

Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer

Anti-Cancer Drugs ◽

10.1097/cad.0b013e3280adc8e0 ◽

2007 ◽

Vol 18 (7) ◽

pp. 835-837 ◽

Cited By ~ 25

Author(s):

Dany Gholam ◽

Amale Chebib ◽

Dominique Hauteville ◽

Marie-Pierre Bralet ◽

Claude Jasmin

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Triple Negative ◽

Growth Factor Receptor ◽

Major Response ◽

Epidermal Growth ◽

Estrogen Receptor Negative

Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer

Applied Immunohistochemistry & Molecular Morphology ◽

10.1097/pai.0000000000000525 ◽

2019 ◽

Vol 27 (1) ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Nosaibah Hariri ◽

Farnaz Hasteh ◽

Vighnesh Walavalkar ◽

Andres A. Roma ◽

Oluwole Fadare

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer

International Journal of General Medicine ◽

10.2147/ijgm.s314055 ◽

2021 ◽

Vol Volume 14 ◽

pp. 2777-2783

Author(s):

Gulijire Tailaiti ◽

Gulanbaier Maimaiti ◽

Youlituzi Aikeremu ◽

Batuer Tuerdi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Invasive Breast Cancer ◽

Growth Factor Receptor ◽

X Ray ◽

Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Indian Journal of Surgery ◽

10.1007/s12262-020-02380-y ◽

2020 ◽

Author(s):

Adarsh Verma ◽

Amrita Ghosh Kar ◽

Ram Niwas Meena ◽

S. C. U. Patne ◽

Shashi Prakash Mishra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2019.07.002 ◽

2019 ◽

Vol 71 ◽

pp. 52-57 ◽

Cited By ~ 4

Author(s):

Yuanwen Chen ◽

Nian Wu ◽

Lei Liu ◽

Huaying Dong ◽

Chengyi Wu

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine therapy (ET)

10.1158/1538-7445.sabcs18-ot1-03-01 ◽

2019 ◽

Author(s):

G Curigliano ◽

S Cresta ◽

Y-S Yap ◽

D Juric ◽

FP Duhoux ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Breast Cancer ◽

Phase 1 ◽

Growth Factor Receptor ◽

Estrogen Receptor Positive ◽

Correlation of Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesterone Receptor (PR) Expression as Predicted by Core Biopsy with the Immunohistochemical Results of Surgical Breast Cancer Specimens

Breast Care ◽

10.1159/000101429 ◽

2007 ◽

Vol 2 (2) ◽

pp. 94-98 ◽

Cited By ~ 2

Author(s):

Julian Erggelet ◽

Regina Grosse ◽

Hans-Jürgen Holzhausen ◽

Steffen Hauptmannb,Christoph Thomssen

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Core Biopsy ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer

Cancer Science ◽

10.1111/cas.12897 ◽

2016 ◽

Vol 107 (4) ◽

pp. 491-498 ◽

Cited By ~ 19

Author(s):

Mai Tomiguchi ◽

Yutaka Yamamoto ◽

Mutsuko Yamamoto‐Ibusuki ◽

Lisa Goto‐Yamaguchi ◽

Yoshitaka Fujiki ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Estrogen Receptor Positive ◽

Effect of Epidermal Growth Factor Receptor Inhibitor on Development of Estrogen Receptor-Negative Mammary Tumors

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djg117 ◽

2003 ◽

Vol 95 (24) ◽

pp. 1825-1833 ◽

Cited By ~ 58

Author(s):

C. Lu ◽

C. Speers ◽

Y. Zhang ◽

X. Xu ◽

J. Hill ◽

...

Keyword(s):

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Mammary Tumors ◽

Epidermal Growth ◽

Estrogen Receptor Negative ◽

Receptor Inhibitor